Banner

DR. RAJIB PAUL

Qualification: M.B.B.S, M.D
Designation / Role: Sr. Consultant Internal Medicine & Critical Care at Apollo Health City
Specialty: Critical Care
Associated MLH Pages: Hospital Care| Viatris See Less

Special interests in:

  • Crtical care
  • Sepsis
  • Nutrition
  • Ards
  • Infections in icu
  • Non invasive hemodynamic monitoring

Member of

  • Indian soceity of critical care medicine (hony. Secretary)
  • Soceity of critical care medicine ( usa )
  • Infection control committee apollo health city
  • Drugs & therapeutics committee apollo health city
  • Transfusion committee apollo health city


Faculty positions

  • Teacher of isccm ( indian society of critical care medicine )
  • Examiner of mcem (member of the royal college of emergency medicine uk. )
  • Faculty of dnb ( internal medicine ) apollo hospital

Course director

  • Apollo critical care nursing

Course instructor

  • American heart association advanced cardiac life support

Trials completed

  • A multi-center, randomized, double-blind, placebo controlled trial of the efficacy and safety of rilonacept for the prophylaxis of gout flares during the initiation of allopurinol therapy.
  • A phase ii/iii seamless, multi-center, randomized, double-blind, placebo- controlled study of the reduction in signs and symptoms and inhibition of structural damage during treatment with tocilizumab versus placebo in patients with ankylosing spondylitis who have failed non-steroidal anti-inflammatory drugs and are naïve to tnf antagonist therapy.
  • A phase 3 randomized, double- blind, parallel- group, multi-centre study of the safety and efficacy of epixaban for prophylaxis of venous thromboembolism in acutely ill medical subjects during and following hospitalization.
  • A randomized, phase 3, controlled, double –blind, parallel-group, multicentre study to evaluate the safety and efficacy of rituximab in combination with methotrexate (mtx) compared to mtx alone, in methotrexate naïve patients with active rheumatoid arthritis”.
  • A phase 3, multicentre, randomized, double-blind, comparative study of the efficacy and safety of tigecycline vs. Imipenem/ cilastatin for the treatment of subjects with hospital- acquired pneumonia.
  • A phase 3, multicenter, multi-national, open-label study to evaluate the safety and efficacy of alfimeprase in subjects with occluded central venous access devices (sonoma-3)
  • A single centre observational study “ intermittent modular plasma adsorption of cytokines and toxins ” in severe sepsis & septic shock ( ongoing )

CME’s conducted

  • Conducted 4 critical care conferences ( 2009, 2010,2012 & 2013 ) each with more than 100 participants from all over hyderabad
  • Conducted 1 ventilator work shop
  • Conducted nutrition workshops for dietcians of hyderabad
  • Numerous cme’s & panel discussions all over hyderabad
  • Weekly cme’s of critical care department
Show more







Account